Dawn Allen Sells 74,679 Shares of Haleon plc (LON:HLN) Stock

Haleon plc (LON:HLN) insider Dawn Allen sold 74,679 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of GBX 372 ($4.66), for a total transaction of £277,805.88 ($348,258.59).

Haleon Trading Up 2.1 %

Shares of HLN stock opened at GBX 380.30 ($4.77) on Friday. The firm has a fifty day moving average of GBX 379.25 and a 200-day moving average of GBX 357.45. The stock has a market cap of £34.38 billion, a price-to-earnings ratio of 3,169.17, a P/E/G ratio of 1.49 and a beta of 0.19. Haleon plc has a 52-week low of GBX 308.37 ($3.87) and a 52-week high of GBX 400.65 ($5.02). The company has a debt-to-equity ratio of 54.18, a quick ratio of 0.93 and a current ratio of 0.84.

Analyst Ratings Changes

Separately, Berenberg Bank increased their target price on shares of Haleon from GBX 410 ($5.14) to GBX 447 ($5.60) and gave the company a “buy” rating in a research note on Monday, August 5th.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.